M

Mekonos Inc.

39 employees

Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Semiconductor
Chipset
Genetic Diseases
Oncology
Robotics
Rare diseases
Gene Therapies
Silicon
MEMS
Drug Development
Nanotechnology
Microfluidics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$25M

from 19 investors over 19 rounds

M

Mekonos Inc. raised $25M on November 9, 2021

Investors: PEAK6, elementum ventures, Reimagined Ventures, Elementum Ventures, Section 32, TDK Ventures and Sands Capital Management

M

Mekonos Inc. raised $4.6M on November 23, 2020

Investors: Hike Ventures, CRCM Ventures, Elementum Ventures, elementum ventures and Good AI Capital

M

Mekonos Inc. raised undisclosed on January 10, 2019

Investors: Matū Group - Raising on Catalist!

M

Mekonos Inc. raised $1.4M on June 4, 2018

Investors: dRx data, Elementum Ventures, Good AI Capital and elementum ventures

M

Mekonos Inc. raised undisclosed on October 15, 2017

Investors: Berkeley SkyDeck and Creative Destruction Lab

FAQ